Richard J. Albertini mostly deals with Molecular biology, Hypoxanthine-guanine phosphoribosyltransferase, Mutant, Genetics and In vivo. His studies in Molecular biology integrate themes in fields like Mutation, Southern blot and Gene. Within one scientific family, he focuses on topics pertaining to Somatic cell under Mutation, and may sometimes address concerns connected to Peripheral blood, Cancer and Environmental exposure.
The various areas that Richard J. Albertini examines in his Hypoxanthine-guanine phosphoribosyltransferase study include Cloning and Cord blood, Immunology, Antigen. His research integrates issues of Sister chromatid exchange, Cancer research and Genotoxicity in his study of Gene mutation. His work in the fields of Carcinogen, such as DNA adduct, intersects with other areas such as Chromosome aberration.
Richard J. Albertini mainly investigates Molecular biology, Genetics, Mutant, Hypoxanthine-guanine phosphoribosyltransferase and Mutation. His study in Molecular biology is interdisciplinary in nature, drawing from both Southern blot, Gene, Somatic cell, Gene mutation and In vivo. His work focuses on many connections between Gene mutation and other disciplines, such as Genotoxicity, that overlap with his field of interest in Metabolite, Micronucleus test, Biochemistry and Environmental exposure.
The Mutant study which covers Complementary DNA that intersects with genomic DNA. His Hypoxanthine-guanine phosphoribosyltransferase study combines topics in areas such as T cell, Cancer and Immunology, Cord blood. The study incorporates disciplines such as Cell culture, Endocrinology, Genome instability and Cancer research in addition to Mutation.
His scientific interests lie mostly in Carcinogen, Molecular biology, Genetics, Genotoxicity and Internal medicine. His Carcinogen research focuses on subjects like Toxicity, which are linked to Pharmacology. Richard J. Albertini combines subjects such as Mutation, Mutant, Micronucleus test and Cytometry with his study of Molecular biology.
His biological study spans a wide range of topics, including Complementary DNA, Cloning, Mutagen and Somatic cell. His Genotoxicity study integrates concerns from other disciplines, such as Metabolite, Biochemistry, Gene mutation and In vivo. His Endocrinology research incorporates elements of Hemoglobin and Hypoxanthine-guanine phosphoribosyltransferase.
His main research concerns Urine, Environmental health, Cohort, Internal medicine and Medical surveillance. He usually deals with Internal medicine and limits it to topics linked to Endocrinology and Hypoxanthine-guanine phosphoribosyltransferase and Globin. His work carried out in the field of Medical surveillance brings together such families of science as Micronucleus test, Urinary system, Cumulative Exposure, Physiology and Veterans Affairs.
His research in Micronucleus test intersects with topics in Genetics and Genotoxicity. Richard J. Albertini has included themes like In vitro, Mutagen, Gene mutation, Molecular biology and In vivo in his Genotoxicity study. The Carcinogen study combines topics in areas such as Mutation, Leukemia and DNA repair.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans
Richard J Albertini;Diana Anderson;George R Douglas;Lars Hagmar.
Mutation Research-reviews in Mutation Research (2000)
T cells responsive to myelin basic protein in patients with multiple sclerosis
Mark Allegretta;Janice A. Nicklas;Subramaniam Sriram;Richard J. Albertini.
Science (1990)
In Vivo Somatic Mutations in Humans: Measurement and Analysis
R J Albertini;J A Nicklas;J P O'Neill;S H Robison.
Annual Review of Genetics (1990)
Enumeration of 6-thioguanine-resistant peripheral blood lymphocytes in man as a potential test for somatic cell mutations arising in vivo.
Gary H. Strauss;Richard J. Albertini.
Mutation Research (1979)
Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans
J.P. O'Neill;M.J. McGinniss;J.K. Berman;L.M. Sullivan.
Mutagenesis (1987)
Alterations of the hprt gene in human in vivo-derived 6-thioguanine-resistant T lymphocytes.
Richard J. Albertini;J. Patrick O'Neill;Janice A. Nicklas;Nicholas H. Heintz.
Nature (1985)
Mitochondrial Genome Damage Associated with Cigarette Smoking
Scott W. Ballinger;T. Glen Bouder;Gerald S. Davis;Stephen A. Judice.
Cancer Research (1996)
Somatic gene mutations in vivo as indicated by the 6-thioguanine-resistant T-lymphocytes in human blood
Richard J. Albertini.
Mutation Research (1985)
Genotoxicity of Radiofrequency Radiation
Genetox Expert Panel;David Brusick;Richard Albertini.
Environmental and Molecular Mutagenesis (1998)
Health effects of depleted uranium on exposed Gulf War veterans: a 10-year follow-up.
Melissa A. McDiarmid;Susan Engelhardt;Marc Oliver;Patricia Gucer.
Journal of Toxicology and Environmental Health (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of North Carolina at Chapel Hill
University of Wisconsin–Madison
United States Food and Drug Administration
National Institutes of Health
National Institutes of Health
Rutgers, The State University of New Jersey
Boston University
University of Wisconsin–Madison
University of California, Berkeley
Stanford University
Fondazione Bruno Kessler
Federal Reserve Bank of Boston
Henan University
Université Catholique de Louvain
Duke University
Children's Hospital of Philadelphia
Institute of Hydrobiology, Biology Centre of the Academy of Sciences of the Czech Republic
University of Valladolid
University of Leicester
University of Bristol
University College London
University of Barcelona
University of Chicago
Wayne State University
University of Lausanne
Stanford University